重组蛋白生产服务市场－全球产业规模、份额、趋势、机会和预测，按服务类型、宿主细胞、最终用户、地区和竞争格局划分，2020-2030年预测

2024年全球重组蛋白生产服务市场规模为37.6亿美元，预计2030年将以7.41%的复合年增长率成长至57.7亿美元。重组蛋白是透过将特定遗传物质导入宿主细胞而人工合成的蛋白质，从而能够大规模生产，用于包括治疗、诊断和研究在内的多种用途。该领域生产服务市场的主要驱动因素包括：全球生物製药研发投资的不断增长、对生物製剂和生物相似药需求的持续扩大，以及需要先进蛋白质疗法的慢性疾病日益增加。

主要市场驱动因素

主要市场挑战

主要市场趋势

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球重组蛋白生产服务市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按服务类型（临床前和临床服务、商业生产服务）
  • 依宿主细胞类型（哺乳动物细胞、细菌细胞、昆虫细胞、酵母和真菌、其他）
  • 按最终用户（製药和生物技术公司、学术和研究机构）划分
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美重组蛋白生产服务市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲重组蛋白生产服务市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区重组蛋白生产服务市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲重组蛋白生产服务市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美洲重组蛋白生产服务市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购（如有）
• 产品发布（如有）
• 最新进展

第十三章：全球重组蛋白生产服务市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• Lonza Group Ltd.
• Boehringer Ingelheim International GmbH
• FUJIFILM Diosynth Biotechnologies USA, Inc.
• Merck KGaA
• Bruker Corporation
• Sino Biological, Inc.
• GenScript Biotech Corporation
• Kaneka Corporation
• Polyplus Transfection SA
• Boster Biological Technology Co., Ltd.

第十六章：策略建议

第17章调查会社について・免责事项

The Global Recombinant Proteins Manufacturing Services Market, valued at USD 3.76 Billion in 2024, is projected to experience a CAGR of 7.41% to reach USD 5.77 Billion by 2030. Recombinant proteins are artificially engineered proteins generated by introducing specific genetic material into host cells, enabling their large-scale production for diverse applications, including therapeutic, diagnostic, and research purposes. The market for manufacturing services in this sector is fundamentally driven by increasing global investments in biopharmaceutical research and development, the expanding demand for biologics and biosimilars, and the growing prevalence of chronic diseases requiring advanced protein-based therapies.

Key Market Drivers

The rising demand for biologics and biosimilars is a primary driver for the global recombinant proteins manufacturing services market. These advanced therapeutic products, leveraging recombinant protein technology, address diverse diseases, and their growing adoption demands specialized production capabilities. Patent expirations for originator biologics have notably fueled the biosimilars sector, increasing product development. Recombinant protein service manufacturers are crucial in supporting this pipeline, providing expertise and infrastructure for complex biological production. This pursuit of more affordable treatments strengthens market demand; according to a study published by RAND Corporation in January 2022, biosimilar drugs are expected to generate savings estimated at USD 38.4 billion of projected total U. S. expenditure on biologics from 2021 to 2025. This economic benefit underscores the need for efficient and scalable manufacturing services.

Key Market Challenges

The inherent complexities in achieving optimal protein expression, ensuring high purity during purification, and maintaining consistent product quality and stability pose a significant impediment to the growth of the global recombinant proteins manufacturing services market. These technical hurdles, including issues such as protein aggregation and the necessity for stringent regulatory compliance across diverse expression systems, directly lead to elevated operational costs and extended development timelines for recombinant protein products. This significantly increases the financial burden on manufacturers and developers.

Key Market Trends

The expansion of biopharmaceutical outsourcing to specialized providers continues to significantly shape the Global Recombinant Proteins Manufacturing Services Market. This trend reflects a strategic shift by pharmaceutical and biotechnology companies to leverage external expertise, advanced technologies, and scalable capacity offered by contract development and manufacturing organizations. This allows companies to optimize resource allocation, reduce capital expenditure, and accelerate time to market for complex protein-based therapies. Lonza's CDMO business, for instance, reported robust performance in its first half of 2025, with sales delivering a 23.1% growth at constant exchange rates. This substantial growth underscores the sustained demand for specialized outsourcing services within the industry.

Key Market Players

• Lonza Group Ltd.
• Boehringer Ingelheim International GmbH
• FUJIFILM Diosynth Biotechnologies USA, Inc.
• Merck KGaA
• Bruker Corporation
• Sino Biological, Inc.
• GenScript Biotech Corporation
• Kaneka Corporation
• Polyplus Transfection S.A.
• Boster Biological Technology Co., Ltd.

Report Scope:

In this report, the Global Recombinant Proteins Manufacturing Services Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Recombinant Proteins Manufacturing Services Market, By Service Type:

• Pre-clinical & Clinical Services
• Commercial Production Services

Recombinant Proteins Manufacturing Services Market, By Host Cell:

• Mammalian Cells
• Bacterial Cells
• Insect Cells
• Yeast & Fungi
• Others

Recombinant Proteins Manufacturing Services Market, By End-user:

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes

Recombinant Proteins Manufacturing Services Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Recombinant Proteins Manufacturing Services Market.

Available Customizations:

Global Recombinant Proteins Manufacturing Services Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Recombinant Proteins Manufacturing Services Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Service Type (Pre-clinical & Clinical Services, Commercial Production Services)
  • 5.2.2. By Host Cell (Mammalian Cells, Bacterial Cells, Insect Cells, Yeast & Fungi, Others)
  • 5.2.3. By End-user (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Recombinant Proteins Manufacturing Services Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Service Type
  • 6.2.2. By Host Cell
  • 6.2.3. By End-user
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Recombinant Proteins Manufacturing Services Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Service Type
      • 6.3.1.2.2. By Host Cell
      • 6.3.1.2.3. By End-user
  • 6.3.2. Canada Recombinant Proteins Manufacturing Services Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Service Type
      • 6.3.2.2.2. By Host Cell
      • 6.3.2.2.3. By End-user
  • 6.3.3. Mexico Recombinant Proteins Manufacturing Services Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Service Type
      • 6.3.3.2.2. By Host Cell
      • 6.3.3.2.3. By End-user

7. Europe Recombinant Proteins Manufacturing Services Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Service Type
  • 7.2.2. By Host Cell
  • 7.2.3. By End-user
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Recombinant Proteins Manufacturing Services Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Service Type
      • 7.3.1.2.2. By Host Cell
      • 7.3.1.2.3. By End-user
  • 7.3.2. France Recombinant Proteins Manufacturing Services Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Service Type
      • 7.3.2.2.2. By Host Cell
      • 7.3.2.2.3. By End-user
  • 7.3.3. United Kingdom Recombinant Proteins Manufacturing Services Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Service Type
      • 7.3.3.2.2. By Host Cell
      • 7.3.3.2.3. By End-user
  • 7.3.4. Italy Recombinant Proteins Manufacturing Services Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Service Type
      • 7.3.4.2.2. By Host Cell
      • 7.3.4.2.3. By End-user
  • 7.3.5. Spain Recombinant Proteins Manufacturing Services Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Service Type
      • 7.3.5.2.2. By Host Cell
      • 7.3.5.2.3. By End-user

8. Asia Pacific Recombinant Proteins Manufacturing Services Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Service Type
  • 8.2.2. By Host Cell
  • 8.2.3. By End-user
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Recombinant Proteins Manufacturing Services Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Service Type
      • 8.3.1.2.2. By Host Cell
      • 8.3.1.2.3. By End-user
  • 8.3.2. India Recombinant Proteins Manufacturing Services Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Service Type
      • 8.3.2.2.2. By Host Cell
      • 8.3.2.2.3. By End-user
  • 8.3.3. Japan Recombinant Proteins Manufacturing Services Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Service Type
      • 8.3.3.2.2. By Host Cell
      • 8.3.3.2.3. By End-user
  • 8.3.4. South Korea Recombinant Proteins Manufacturing Services Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Service Type
      • 8.3.4.2.2. By Host Cell
      • 8.3.4.2.3. By End-user
  • 8.3.5. Australia Recombinant Proteins Manufacturing Services Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Service Type
      • 8.3.5.2.2. By Host Cell
      • 8.3.5.2.3. By End-user

9. Middle East & Africa Recombinant Proteins Manufacturing Services Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Service Type
  • 9.2.2. By Host Cell
  • 9.2.3. By End-user
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Recombinant Proteins Manufacturing Services Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Service Type
      • 9.3.1.2.2. By Host Cell
      • 9.3.1.2.3. By End-user
  • 9.3.2. UAE Recombinant Proteins Manufacturing Services Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Service Type
      • 9.3.2.2.2. By Host Cell
      • 9.3.2.2.3. By End-user
  • 9.3.3. South Africa Recombinant Proteins Manufacturing Services Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Service Type
      • 9.3.3.2.2. By Host Cell
      • 9.3.3.2.3. By End-user

10. South America Recombinant Proteins Manufacturing Services Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Service Type
  • 10.2.2. By Host Cell
  • 10.2.3. By End-user
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Recombinant Proteins Manufacturing Services Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Service Type
      • 10.3.1.2.2. By Host Cell
      • 10.3.1.2.3. By End-user
  • 10.3.2. Colombia Recombinant Proteins Manufacturing Services Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Service Type
      • 10.3.2.2.2. By Host Cell
      • 10.3.2.2.3. By End-user
  • 10.3.3. Argentina Recombinant Proteins Manufacturing Services Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Service Type
      • 10.3.3.2.2. By Host Cell
      • 10.3.3.2.3. By End-user

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Recombinant Proteins Manufacturing Services Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Lonza Group Ltd.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Boehringer Ingelheim International GmbH
• 15.3. FUJIFILM Diosynth Biotechnologies USA, Inc.
• 15.4. Merck KGaA
• 15.5. Bruker Corporation
• 15.6. Sino Biological, Inc.
• 15.7. GenScript Biotech Corporation
• 15.8. Kaneka Corporation
• 15.9. Polyplus Transfection S.A.
• 15.10. Boster Biological Technology Co., Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer